Country music star supports JDRF
NEW YORK Country music recording artist George Canyon is supporting the Juvenile Diabetes Research Foundation by letting fans download his hit single, “I Believe in Angels,” for free off of his website.
A donation will be made to JDRF on behalf of each download through the month. The promotion is in honor of November’s Diabetes Awareness Month and World Diabetes Day 2010 on Nov. 14.
Juvenile diabetes, also known as Type 1 diabetes, is a condition that hits home for Canyon; he was diagnosed with the condition at 14 years old.
“George Canyon has not let Type 1 diabetes get in the way of achieving his dreams of becoming a singer,” said Claire Schultz, SVP marketing and communications for JDRF. “A long-time partner of our JDRF affiliate in Canada, we are pleased to have George Canyon reach audiences all over the U.S., and are grateful for support of JDRF.”
Walgreens continues vitamin D giveaway program with Aetna, United Way
COLUMBIA , S.C. (May 27) One of the nation’s largest drug store chains has teamed up with a healthcare benefits company and a community solutions provider to raise awareness of the need for adequate vitamin D intake.
Walgreens, Aetna and United Way of the Midlands are continuing their efforts through a vitamin D giveaway program extension, which initially was kicked off earlier this year. The vitamin D awareness efforts will donate more than 25,000 samples, the companies said.
“We are pleased to continue our participation in this program to drive awareness around a health concern that’s seldom discussed in many communities,” said Richard Ashworth, Walgreens market VP. “Our goal is for more people to be informed that supporting a proper diet and healthy lifestyle with a vitamin D supplement is a simple step that can have long-term health benefits.”
FDA: Tri-Med selling unapproved, adulterated drugs
SILVER SPRING, Md. U.S. Marshals earlier this month seized articles of prescription and over-the-counter drug products from Tri-Med Labs in Somerset, N.J., at the request of the Food and Drug Administration, the agency announced Wednesday. The seizure warrant, issued by the U.S. District Court for the District of New Jersey and unsealed this week, shows the drugs are unapproved and adulterated new drugs.
“The FDA is taking this action because Tri-Med has refused to take these unapproved products off the market after it received warning letters and regulatory meetings,” stated Dara Corrigan, the FDA’s associate commissioner for regulatory affairs. “This action shows the FDA’s commitment to protecting the public health from the dangers of unapproved or adulterated drug products.”
The FDA has been on the case approaching 13 years — FDA inspections of Tri-Med since 1997 revealed Tri-Med continued to manufacture and distribute unapproved, misbranded and adulterated drugs with significant Good Manufacturing Practices violations.